Back
Home
Search
Non-Production - Platinum Sensitive
Protocols
UW24116
OPEN TO ACCRUAL
Ph2 trial of Mirvetuximab Soravtansine & Olaparib in Ovarian Peritoneal & Fallopian Tube Cancer